Ortiz et al. [91] hypothesized that FKBP5 methylation is associated with potential glucocorticoid pathway dysfunction as an underlying pathophysiology of diabetes, hyperglycemia, hyperlipidemia, obesity, and cardiometabolic disease. Here, FKBP5 is linked to diabetes mellitus.